CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 136 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,649 | +9.3% | 24,692 | +25.7% | 0.00% | 0.0% |
| Q2 2023 | $264,069 | -18.9% | 19,648 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $325,764 | +15.1% | 19,648 | +29.1% | 0.00% | 0.0% |
| Q4 2022 | $283,148 | +137.9% | 15,223 | +64.8% | 0.00% | +100.0% |
| Q3 2022 | $119,000 | +83.1% | 9,240 | 0.0% | 0.00% | – |
| Q2 2022 | $65,000 | -52.6% | 9,240 | -44.1% | 0.00% | -100.0% |
| Q1 2022 | $137,000 | +144.6% | 16,535 | +99.8% | 0.00% | – |
| Q4 2021 | $56,000 | +51.4% | 8,277 | +19.9% | 0.00% | – |
| Q3 2021 | $37,000 | -7.5% | 6,904 | 0.0% | 0.00% | – |
| Q2 2021 | $40,000 | +25.0% | 6,904 | 0.0% | 0.00% | – |
| Q1 2021 | $32,000 | +39.1% | 6,904 | 0.0% | 0.00% | – |
| Q4 2020 | $23,000 | +9.5% | 6,904 | 0.0% | 0.00% | – |
| Q3 2020 | $21,000 | -34.4% | 6,904 | 0.0% | 0.00% | – |
| Q2 2020 | $32,000 | +18.5% | 6,904 | 0.0% | 0.00% | – |
| Q1 2020 | $27,000 | +3.8% | 6,904 | 0.0% | 0.00% | – |
| Q4 2019 | $26,000 | -29.7% | 6,904 | 0.0% | 0.00% | – |
| Q3 2019 | $37,000 | +54.2% | 6,904 | +9.4% | 0.00% | – |
| Q2 2019 | $24,000 | – | 6,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |